Kolkata, West Bengal -- (SBWIRE) -- 09/16/2013 -- Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on Boston Scientific Corporation (NYSE:BSX), Alpha Natural Resources, Inc. (NYSE:ANR), Apollo Senior Floating Rate Fund Inc (NYSE:AFT).
Boston Scientific Corporation (NYSE:BSX) shares declined 0.59% to $11.84. In a significant milestone toward obtaining additional key regulatory approvals for the SYNERGY(TM)( )Stent System, Boston Scientific Corporation (NYSE: BSX) on Sept. 12 has completed enrollment in the EVOLVE II randomized, controlled clinical trial. The EVOLVE II trial is designed to further assess the safety and effectiveness of the SYNERGY Stent System and support U.S. Food and Drug Administration and Japanese regulatory approvals for the treatment of atherosclerotic coronary lesions.
Additionally, BSX’s stock was downgraded by stock analysts at CL King from a “buy” rating to a “neutral” rating in a report issued on Sept. 10. Separately, BSX’s stock has been upgraded by TheStreet Ratings from hold to buy on Sept. 2.
Should Investors Buy BSX After Yesterday’s Jump? Find Out Here
Alpha Natural Resources, Inc. (NYSE:ANR) shares decreased 2.36% to $6.21. Alpha Natural on Sept. 6 has been initiated with an Underperform at Macquarie on Sept. 6 with a price target of $5.
Additionally, the company on August 28 announced topline results from the ongoing phase 2 of SGI-110 in patients with AML and MDS. The Phase 2 study is a randomized study of SGI-110 given either as 60 or 90 mg/m2 daily for 5 days in a 28-day course. As of end of June data cutoff, 67 AML patients had a minimum follow up of 3 months (50 patients representing the complete cohort of relapsed/refractory AML, and 17 patients in the treatment-naive elderly AML not suitable for induction chemotherapy cohort).
How Should Investors Trade ANR After The Recent Volatility? Get Free Trend Analysis Here
Apollo Senior Floating Rate Fund Inc (NYSE:AFT) shares jumped 0.11% and closed at $1818 in the last trading session. The company will begin trading ex-dividend on September 16, 2013. A cash dividend payment of $0.101 per share is scheduled to be paid on September 30, 2013. Shareholders who purchased AFT stock prior to the ex-dividend date are eligible for the cash dividend payment. At the current stock price of $18.16, the dividend yield is 6.67%.
Is AFT A Good Buy After The Recent Price Movement? Find Out Here
Specialpennystockalert.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Specialpennystockalert.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at Specialpennystockalert.com.
The assembled information disseminated by Specialpennystockalert.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Specialpennystockalert.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)